Table 1.
Demographic Details and Clinical Scores assessed at baseline.
| Characteristics | Parkinson's Disease | Essential Tremor |
|---|---|---|
| Sex (m/f) | 9/5 | 11/5 |
| Age: Mean (SD) | 68.6 (7.86) | 65.4 (11.69) |
| Age of disease onset: Mean (SD) | 63.2 (7.21) | 41.7 (24.91) |
| Disease Duration: Mean (SD) | 5.4 (2.6) | 23.7 (20.00) |
| MDS UPDRS III: Mean (SD) | 35.6 (8.45) | NA |
| TETRAS Performance: Mean (SD) | NA | 18.8 (5.25) |
| MDS-UPDRS 3.17 + 3.18; more affected hand: Mean (SD) [Range] | 4.1 (1.2) [2–6] | NA |
| TETRAS 4a R + L: Mean (SD) [Range] | NA | 2.6 (1.2) [1–4.5] |
| Daily Levodopa Equivalence Dose: Mean (SD) [Range] | 471.64 (291.78) [52–1246] | NA |
Description: SD = Standard deviation; MDS UPDRS III = Movement Disorders Society Unified Parkinson's Disease Rating Scale, Part III Motor function at Baseline; TETRAS Performance = The Essential Tremor Rating Scale Performance Part at Baseline; Baseline = 12 h after the last intake of anti-tremor medication; NA = not applicable.